Book Profits On Puma Biotechnology – Cramer’s Lightning Round (8/7/17) – Seeking Alpha

Posted: Published on August 11th, 2017

This post was added by Dr P. Richardson

Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Monday, August 7.

Philip Morris International (NYSE:PM): "No, don't sell it. I think they have a lot more optionality. I would not sell that here. And remember, I think the dollar's getting very weak still."

Blue Apron (NYSE:APRN): Cramer doesn't see upside.

International Game Technology (NYSE:IGT): It's an inexpensive stock but does not have a growth catalyst.

Eaton Corp (NYSE:ETN): Their quarter was not good. Cramer prefers Honeywell (NYSE:HON) or 3M (NYSE:MMM).

DaVita (NYSE:DVA): No. Cramer prefers Boston Scientific (NYSE:BSX) in that group.

Puma Biotechnology (NYSE:PBYI): It has had a big run. Book profits.

Masimo Corp (NASDAQ:MASI): Cramer just prefers Intuitive Surgical (NASDAQ:ISRG) in that group.

::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

Jim Cramer's Action Alerts PLUS: Check out Cramer's multi-million dollar charitable trust portfolio and uncover the stocks he thinks could be HUGE winners. Start your FREE 14-day trial now!

Get Cramer's Picks by email - it's free and takes only a few seconds to sign up

Read more from the original source:
Book Profits On Puma Biotechnology - Cramer's Lightning Round (8/7/17) - Seeking Alpha

Related Posts
This entry was posted in Biotechnology. Bookmark the permalink.

Comments are closed.